UY29731A1 - Sal benzoato de 4-(5-metilozazola(4,5-b) piridin-2-il)-1,4-diazabiciclo(3.2.2)nonano - Google Patents

Sal benzoato de 4-(5-metilozazola(4,5-b) piridin-2-il)-1,4-diazabiciclo(3.2.2)nonano

Info

Publication number
UY29731A1
UY29731A1 UY29731A UY29731A UY29731A1 UY 29731 A1 UY29731 A1 UY 29731A1 UY 29731 A UY29731 A UY 29731A UY 29731 A UY29731 A UY 29731A UY 29731 A1 UY29731 A1 UY 29731A1
Authority
UY
Uruguay
Prior art keywords
nonano
benzoate salt
metilozazola
diazabiciclo
piridin
Prior art date
Application number
UY29731A
Other languages
English (en)
Inventor
Allen Jacob Duplantier
Kenneth George Kraus
Bruce Nelsen Rogers
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY29731A1 publication Critical patent/UY29731A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona una sal benzoato de fórmula I: La fórmula I es también conocida como 4-(5-metiloxazolo(4,5-b(beta)piridin-2-il)-1,4-diazabiciclo(3.2.2)nonano. La sal benzoato de la invneicón es útil en el tratamiento de esquizofrenia y enfermedad de Alzheimer. Es particularmente útil en el tratamiento de déficit cognitivos asociados a esquizofrenia, síntomas de déficit cognitivo y de atención de la enfermedad de Alzheimer y neurodegeneración asociada a la enfermedad de Alzheimer.
UY29731A 2005-08-08 2006-08-08 Sal benzoato de 4-(5-metilozazola(4,5-b) piridin-2-il)-1,4-diazabiciclo(3.2.2)nonano UY29731A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70660105P 2005-08-08 2005-08-08

Publications (1)

Publication Number Publication Date
UY29731A1 true UY29731A1 (es) 2007-03-30

Family

ID=37398316

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29731A UY29731A1 (es) 2005-08-08 2006-08-08 Sal benzoato de 4-(5-metilozazola(4,5-b) piridin-2-il)-1,4-diazabiciclo(3.2.2)nonano

Country Status (6)

Country Link
AR (1) AR055111A1 (es)
DO (1) DOP2006000185A (es)
NL (1) NL1032286C2 (es)
TW (1) TW200738734A (es)
UY (1) UY29731A1 (es)
WO (1) WO2007017750A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009113950A1 (en) * 2008-03-10 2009-09-17 Astrazeneca Ab Therapeutic combinations of (a) an antipsychotic and (b) an alpha-4/beta-2 (a4b2)-neuronal nicotinic receptor agonist
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
EP3558276A1 (en) 2016-12-20 2019-10-30 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
CN115813888A (zh) 2016-12-20 2023-03-21 罗曼治疗系统股份公司 包含阿塞那平的透皮治疗系统
CN107188900B (zh) * 2017-05-27 2019-09-06 北京师范大学 α7烟碱型乙酰胆碱受体的配体化合物及其应用
JP2020525545A (ja) 2017-06-26 2020-08-27 エルテーエス ローマン テラピー−ジステーメ アーゲー アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム
MX2020014286A (es) 2018-06-20 2021-03-25 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086871A1 (en) * 2000-12-29 2002-07-04 O'neill Brian Thomas Pharmaceutical composition for the treatment of CNS and other disorders
EP1699488A2 (en) * 2003-12-23 2006-09-13 Pfizer Products Incorporated Therapeutic combination for cognition enhancement and psychotic disorders

Also Published As

Publication number Publication date
DOP2006000185A (es) 2007-03-31
NL1032286C2 (nl) 2007-08-07
TW200738734A (en) 2007-10-16
NL1032286A1 (nl) 2007-02-09
WO2007017750A1 (en) 2007-02-15
AR055111A1 (es) 2007-08-08

Similar Documents

Publication Publication Date Title
UY29731A1 (es) Sal benzoato de 4-(5-metilozazola(4,5-b) piridin-2-il)-1,4-diazabiciclo(3.2.2)nonano
DK2276485T3 (da) Anvendelse af epothilon d i behandling af tau-associerede sygdomme,herunder alzheimers sygdom
DE602008004643D1 (de) 1-ä2-(2,4-dimethylphenylsulfanyl)phenylüpiperazin als verbindung mit kombinierter serotonin-aufnahme, 5-ht3- und 5-ht1a-aktivität zur behandlung von schmerzen oder restsymptomen bei depressionen im zusammenhang mt schlaf und kognition
CR20150131A (es) Derivados piridin-2-il-amino-1,2,4-tiadiazol como activadores glucoquinasa para el tratamiento de la diabetes mellitus
ME01032B (me) FORME RIFAKSIMINA l NJIHOVA UPOTREBA
RU2711869C3 (ru) Имидазопирролопиразиновые производные, полезные для лечения заболеваний, вызванных аномальной активностью протеинкиназ Jak1, Jak3 или Syk
ATE495445T1 (de) Verfahren und zusammensetzungen in verbindung mit morbus alzheimer
MX2013001614A (es) Compuestos heterociclico.
CO6210752A2 (es) Compuestos biciclicos y uso como antidiabeticos
CO6311079A2 (es) Derivados de aminodihidrotiazina como inhibidores de la enzima bace para el tratamiento de la enfermedad de alzheimer
ECSP12011622A (es) Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurológicos
CL2012003427A1 (es) Compuestos derivados de 5-amino-3,6-dihidro-1h-pirazina-2-ona; y uso en el tratamiento de enfermedades tales como alzheimer, senilidad, demencia, entre otras.
GT200600011A (es) Procedimientos para preparar eteres de pirazolo [3,4-d] pirimidina
CL2008002689A1 (es) Compuestos derivados de heterociclo 1,4 piperidina sustituida; compuestos intermediarios; composicion farmaceutica; proceso de preparacion; y su uso en el tratamiento del alzheimer y esquizofrenia.
TW200736233A (en) Cyclohexyl piperazinyl methanone derivatives
UY29964A1 (es) Formas de cristal f,g,h,i, y k del mesilato de imatinib
IN2012DN05186A (es)
ATE556708T1 (de) Corrole für neuroprotektion und neuro-rescue
CR11447A (es) Moduladores de piperidinil y piperazinil de y secretasa
ATE407126T1 (de) Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on
ECSP088280A (es) Compuestos de imidazol para el tratamiento de trastornos neurológicos
CL2008000726A1 (es) Compuestos derivados de heterociclos nitrogenados condensados; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como esquizofrenia, alzheimer, entre otras.
DE602007012272D1 (de) Difluorierte piperidine zur behandlung von morbus alzheimer und verwandten leiden
NI201000067A (es) Intermediarios de gsm.
ATE496047T1 (de) Phenylen-bis-oxazolidin-derivate und ihre verwendung als antikoagulantien

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160830